Effect of Myriocin on Plasma Sphingolipid Metabolism and Atherosclerosis in apoE-deficient Mice
Open Access
- 1 March 2005
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 280 (11), 10284-10289
- https://doi.org/10.1074/jbc.m412348200
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Disruption of sphingolipid homeostasis by myriocin, a mycotoxin, reduces thymic and splenic T-lymphocyte populationsToxicology, 2004
- Predicting obstructive coronary artery disease with serum sphingosine-1-phosphateAmerican Heart Journal, 2003
- Enzymes of Sphingolipid Metabolism: From Modular to Integrative SignalingBiochemistry, 2001
- Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levelsJCI Insight, 1999
- Zn2+-stimulated Sphingomyelinase Is Secreted by Many Cell Types and Is a Product of the Acid Sphingomyelinase GeneJournal of Biological Chemistry, 1996
- Serine Palmitoyltransferase Is the Primary Target of a Sphingosine-like Immunosuppressant, ISP-1/MyriocinBiochemical and Biophysical Research Communications, 1995
- An update of the enzymology and regulation of sphingomyelin metabolismBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- IntroductionThe American Journal of Cardiology, 1990
- Dyslipidemias with desirable plasma total cholesterol levels and angiographically demonstrated coronary artery diseaseThe American Journal of Cardiology, 1990
- Activities of the initial enzymes of glycerolipid and sphingolipid synthesis in lung microsomes from rats exposed to air or 85% oxygenBiochemical and Biophysical Research Communications, 1984